Sean F. Scanlan - 09 Aug 2025 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Innovation Officer
Signature
/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Issuer symbol
TMCI
Transactions as of
09 Aug 2025
Net transactions value
$0
Form type
4
Filing time
12 Aug 2025, 21:30:07 UTC
Previous filing
22 Jul 2025
Next filing
28 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scanlan Sean F. Chief Innovation Officer C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan 12 Aug 2025 0001856371

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Tax liability $0 -9,814 -2.6% $0.000000 373,807 09 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 284,798 restricted stock units.